Overview
Status
Active
Registry date
2023-08-21
Share capital
5,000.00 PLN
Registered address
ul. Złota 75A/7, 00-819 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Hassan Ahmed Abdelrazek – President of the Management Board
Saber Elsayed Ali Elsayed – Management Board Member
Wael Mohamed Zahranage 45 – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hassan Mzahem Ahmed Abdelrazek | 50 | $675.31 | 50% |
Saber Mohamed Elsayed Ali Elsayed | 50 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company Europe Pharma.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of Europe Pharma focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on August 21, 2023.
The headquarters is located at: ul. Złota 75A, 00-819 Warszawa.
The management board includes Wael Mohamed Zahran (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-25